Related Experiment Videos
Bilirubin production after supplemental oral vitamin E therapy in preterm infants
Insights
Early vitamin E supplementation did not significantly alter bilirubin production in preterm infants. Placebo-supplemented infants also achieved vitamin E sufficiency and reduced bilirubin by day 7.
Area of Science:
- Neonatal Medicine
- Pediatric Nutrition
- Biochemistry
Background:
- Preterm infants are susceptible to oxidative stress.
- Heme catabolism leads to bilirubin production, a potential concern in neonates.
- Vitamin E is a key antioxidant investigated for neonatal health benefits.
Purpose of the Study:
- To investigate the impact of early vitamin E supplementation on heme catabolism in healthy preterm infants.
- To assess the influence on bilirubin production rates.
- To compare outcomes between vitamin E and placebo groups.
Main Methods:
- Double-blind, randomized study of 30 preterm infants.
- Measurement of end-tidal carbon monoxide to estimate bilirubin production.
- Assay of serum vitamin E, hemoglobin, and bilirubin levels on days 1, 3, and 7.
Main Results:
- Both groups showed increased vitamin E levels by day 7.
- Bilirubin production did not differ significantly on day 3 but decreased by day 7 in both groups.
- No significant differences in hemoglobin or serum bilirubin between groups.
Conclusions:
- Vitamin E supplementation effectively increases vitamin E levels in preterm infants.
- Placebo-treated preterm infants naturally achieve vitamin E sufficiency and reduced bilirubin production by day 7.
- Early vitamin E supplementation may not be critical for reducing bilirubin production in healthy preterm infants by day 7.
Abstract:
The purpose of this investigation was to determine the influence of early vitamin E supplementation on the rate of heme catabolism (bilirubin production) in healthy preterm infants. Bilirubin production was estimated from the concentration of carbon monoxide in "end-tidal" gas. Serum vitamin E, hemoglobin, and bilirubin levels were determined by standard techniques. Thirty infants received supplementation with vitamin E or placebo in a double-blind, randomized fashion. Infants were studied on day 1 of life prior to therapy, and on days 3 and 7 postnatally. Results showed that in both placebo-supplemented and vitamin E-supplemented groups, vitamin E levels were significantly higher on days 3 and 7 compared with day 1. Bilirubin production was not significantly different on day 3 compared with day 1 in either group, but was significantly lower in both groups by day 7 compared with day 1. There were no significant differences in hemoglobin and serum bilirubin levels between the two groups at any point in time. In conclusion, although vitamin E supplementation significantly raises vitamin E levels, placebo-supplemented premature infants also achieve vitamin E sufficiency and a decrease in bilirubin production by day 7 of age.